EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Medmix AG's enterprise value is CHF901.8 Mil.
Medmix AG's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was CHF71.4 Mil. Therefore, Medmix AG's EV-to-EBITDA for today is 12.63.
The historical rank and industry rank for Medmix AG's EV-to-EBITDA or its related term are showing as below:
XSWX:MEDX'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 6.97 Med: 13.1 Max: 36.3
Current: 12.63
During the past 6 years, the highest EV-to-EBITDA of Medmix AG was 36.30. The lowest was 6.97. And the median was 13.10.
XSWX:MEDX's EV-to-EBITDA is ranked better than 55.34% of 2461
companies
in the Industrial Products industry
Industry Median: 14.2
vs XSWX:MEDX: 12.63
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2024-05-26), Medmix AG's stock price is CHF16.74.
Medmix AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was CHF0.010. Therefore, Medmix AG's PE Ratio for today is 1,674.00.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
Medmix AG EV-to-EBITDA Historical Data
The historical data trend for Medmix AG's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Medmix AG's EV-to-EBITDA
For the Specialty Industrial Machinery subindustry, Medmix AG's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medmix AG's EV-to-EBITDA Distribution in the Industrial Products Industry
For the Industrial Products industry and Industrials sector, Medmix AG's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Medmix AG's EV-to-EBITDA falls into.
Medmix AG EV-to-EBITDA Calculation
Medmix AG's EV-to-EBITDA for today is calculated as:
Medmix AG's current Enterprise Value is CHF901.8 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Medmix AG's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was CHF71.4 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medmix AG (XSWX:MEDX) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Medmix AG's share price for today is CHF16.74.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Medmix AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was CHF0.010.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of Medmix AG's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Medmix AG delivers technologies in high-precision delivery devices and fluid mixing for applications. It is into two business areas Healthcare and Consumer & Industrial. The Healthcare business area is divided into the Dental, Drug Delivery and Surgery segments. The Consumer & Industrial business area operates through the Industry and Beauty segments. The majority of revenue is from Consumer & Industrial segment. In the Industry segment, dispensers, cartridges, and mixers are used in the construction, transportation (automotive, railways and aerospace), electronics assembly, infrastructure and DIY industries. Geographically, it operates in Europe the Middle East and Africa, the Americas and Asia-Pacific.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XSWX:MEDX has been successfully added to your 